Board of GlaxoSmithkline Consumer Healthcare takes on record sanction of scheme of merger

At meeting held on 01 April 2020

The Board of GlaxoSmithkline Consumer Healthcare at its meeting held on 01 April 2020 has taken on record the sanction of the Scheme of merger by way of absorption of the company into Hindustan Unilever by Hon'ble NCL T Mumbai Bench and Chandigarh Bench.

Wednesday, 01 April 2020, has been fixed as the Effective Date of the Scheme and on which date the certified copy of the Hon'ble NCLT, Chandigarh Bench's order will be filed with the Registrar of Companies.

The Appointed Date of the Scheme is 01 April 2020 i.e., the Effective Date, as set out in the Scheme and approved by the' Hon'ble NCLT, Mumbai Bench and Chandigarh Bench. All the assets and liabilities of Transferor Company shall become assets and liabilities of the Transferee Company with effect from the Appointed Date.

The Board has approved the record date of 17 April 2020 for allotment of 4.39 equity shares of Hindustan Unilever for each share of the company.

Powered by Capital Market - Live News